InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the full record of transactions filed by Doherty Catherine T., Deputy Chief Executive. Officer active across 1 companies, notably Quest Diagnostics INC. Cumulatively, 7 reports have been recorded. Total volume traded: €2.3m. The latest transaction was disclosed on 7 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€2m13,392 shares@ €119.62820.0084% mcap15.4% of flow
Common Stock
SEC:0001022079-22-000054:0·
€307,1152,750 shares@ €111.67820.0016% mcap3.0% of flow
Common Stock
SEC:0001022079-22-000039:0·
€124,2441,082 shares@ €114.82780.0006% mcap1.2% of flow
Common Stock
SEC:0001022079-22-000015:0·
€3m37,565 shares@ €84.82550.017% mcap76.3% of flow
Common Stock
SEC:0001022079-21-000146·
€3m37,565 shares@ €84.82550.017% mcap30.7% of flow
Common Stock
SEC:0001022079-21-000146:0·
€989,9488,536 shares@ €115.97330.0052% mcap23.7% of flow
Common Stock
SEC:0001022079-21-000077·
€989,9488,536 shares@ €115.97330.0052% mcap9.5% of flow
Common Stock
SEC:0001022079-21-000077:0·
7 of 7 declarations
About Doherty Catherine T.
Catherine T. Doherty is the Executive Vice President and Group Executive of Clinical Affairs at Quest Diagnostics Inc. She oversees the company's clinical operations, ensuring that services are delivered efficiently and with quality. With significant experience in the diagnostics sector, she plays a key role in optimizing processes and enhancing patient experience. Her leadership is essential for ensuring the company's growth and profitability.
